Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Statistics

Total Valuation

ALLO has a market cap or net worth of $690.31 million. The enterprise value is $504.47 million.

Market Cap	690.31M
Enterprise Value	504.47M

Important Dates

The last earnings date was Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ALLO has 345.15 million shares outstanding. The number of shares has increased by 9.93% in one year.

Current Share Class	345.15M
Shares Outstanding	345.15M
Shares Change (YoY)	+9.93%
Shares Change (QoQ)	+6.31%
Owned by Insiders (%)	3.26%
Owned by Institutions (%)	42.83%
Float	269.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.76
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.65, with a Debt / Equity ratio of 0.29.

Current Ratio	9.65
Quick Ratio	9.47
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-153.33

Financial Efficiency

Return on equity (ROE) is -52.32% and return on invested capital (ROIC) is -28.14%.

Return on Equity (ROE)	-52.32%
Return on Assets (ROA)	-25.97%
Return on Invested Capital (ROIC)	-28.14%
Return on Capital Employed (ROCE)	-51.09%
Weighted Average Cost of Capital (WACC)	6.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.14M
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +80.18% in the last 52 weeks. The beta is 0.46, so ALLO's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+80.18%
50-Day Moving Average	2.31
200-Day Moving Average	1.68
Relative Strength Index (RSI)	41.48
Average Volume (20 Days)	6,234,287

Short Selling Information

The latest short interest is 36.86 million, so 10.68% of the outstanding shares have been sold short.

Short Interest	36.86M
Short Previous Month	36.38M
Short % of Shares Out	10.68%
Short % of Float	13.67%
Short Ratio (days to cover)	2.38

Income Statement

Revenue	n/a
Gross Profit	-131.96M
Operating Income	-187.83M
Pretax Income	-173.76M
Net Income	-173.76M
EBITDA	-175.71M
EBIT	-187.83M
Earnings Per Share (EPS)	-$0.77

Balance Sheet

The company has $266.89 million in cash and $81.05 million in debt, with a net cash position of $185.84 million or $0.54 per share.

Cash & Cash Equivalents	266.89M
Total Debt	81.05M
Net Cash	185.84M
Net Cash Per Share	$0.54
Equity (Book Value)	278.88M
Book Value Per Share	1.14
Working Capital	244.96M

Cash Flow

In the last 12 months, operating cash flow was -$109.23 million and capital expenditures -$296,000, giving a free cash flow of -$109.53 million.

Operating Cash Flow	-109.23M
Capital Expenditures	-296,000
Depreciation & Amortization	12.13M
Net Borrowing	n/a
Free Cash Flow	-109.53M
FCF Per Share	-$0.32

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.93%
Shareholder Yield	-9.93%
Earnings Yield	-25.17%
FCF Yield	-15.87%

Analyst Forecast

The average price target for ALLO is $8.35, which is 317.50% higher than the current price. The consensus rating is "Buy".

Price Target	$8.35
Price Target Difference	317.50%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1